Pharmacological targeting of xCT/system Xc- to modulate temozolomide sensitivity in glioma and glioblastoma preclinical models: a focused systematic review.
- DOI
- 10.1007/s00280-026-04957-y
- Published
- 2026 Oct 9
- Container
- Cancer chemotherapy and pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-026-04957-y,
title = {Pharmacological targeting of xCT/system Xc- to modulate temozolomide sensitivity in glioma and glioblastoma preclinical models: a focused systematic review.},
author = {Elhashani S and Elkawafi M and El Shekhi A and Elrishe S and Aloriby MA},
year = {2026},
journal = {Cancer chemotherapy and pharmacology},
doi = {10.1007/s00280-026-04957-y},
url = {https://doi.org/10.1007/s00280-026-04957-y}
}RIS
TY - JOUR TI - Pharmacological targeting of xCT/system Xc- to modulate temozolomide sensitivity in glioma and glioblastoma preclinical models: a focused systematic review. AU - Elhashani S AU - Elkawafi M AU - El Shekhi A AU - Elrishe S AU - Aloriby MA PY - 2026 JO - Cancer chemotherapy and pharmacology DO - 10.1007/s00280-026-04957-y UR - https://doi.org/10.1007/s00280-026-04957-y ER -
APA
S, E., M, E., A, E. S., S, E., & MA, A. (2026). Pharmacological targeting of xCT/system Xc- to modulate temozolomide sensitivity in glioma and glioblastoma preclinical models: a focused systematic review.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-026-04957-y
Source records
- pubmed · retrieved 2026-11-10T11:47:30.202Z